Tenax Therapeutics, Inc. (TENX) — Dilution Risk Analysis
Current Snapshot
Tenax Therapeutics, Inc. (TENX) has a DilutionWatch score of 52/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 52/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: XBRL 1, EFFECT 1, S-3 1, 4 7.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-5746-xbrl_warrant |
| EFFECT | 2026-04-01 | 9999999995-26-001052 |
| S-3 | 2026-03-24 | 0001654954-26-002661 |
| 4 | 2026-02-03 | 0001550701-26-000001 |
| 4 | 2026-01-13 | 0001713932-26-000001 |
| 4 | 2026-01-13 | 0001704234-26-000001 |
| 4 | 2026-01-13 | 0001492647-26-000001 |
| 4 | 2026-01-13 | 0001279191-26-000001 |
| 4 | 2026-01-13 | 0001841785-26-000001 |
| 4 | 2026-01-13 | 0001871714-26-000001 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $300,000,000 | Source |
| Cash runway | 61 months | Source |
| Three-year share count growth | 1468.32% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 52/10) Source
- Cash Runway
- 61 months Source
- Shelf Registration Capacity
- $300,000,000 Source
- Share Count Growth (3-Year)
- 1468.32% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.